Phosphonamide inhibitors of neutral endopeptidase (EC 3.4.24.11).
Norcini
G
G
R&D, Zambon Group Spa, Bresso Milan, Italy.
Morazzoni
G
G
Pocchiari
F
F
Santangelo
F
F
Semeraro
C
C
D000577:Amides; D000806:Angiotensin-Converting Enzyme Inhibitors / Q000494:pharmacology; D000818:Animals; D009320:Atrial Natriuretic Factor / Q000378:metabolism / Q000494:pharmacology; D001665:Binding Sites; D006020:Glycopeptides / Q000494:pharmacology; D006333:Heart Failure / Q000188:drug therapy; D015394:Molecular Structure; D015260:Neprilysin / Q000037:antagonists & inhibitors*; D009943:Organophosphorus Compounds; D011480:Protease Inhibitors / Q000138:chemical synthesis / Q000494:pharmacology*; D011817:Rabbits; D051381:Rats
D000577:Amides; D000806:Angiotensin-Converting Enzyme Inhibitors; D006020:Glycopeptides; D009943:Organophosphorus Compounds; D011480:Protease Inhibitors; D009320:Atrial Natriuretic Factor; D015260:Neprilysin; C008890:phosphoramidon